Project Grant HT94252510404
Award Date
6/1/25
Completion Date
5/31/29
Dollars Obligated
$2.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
This $729,690 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports metabolic intervention research to halt pancreatic cancer at Cedars-Sinai Medical Center in West Hollywood, California. The project will run from November 1, 2024 to October 31, 2027, investigating innovative approaches to disease prevention, diagnosis, treatment, and management of pancreatic cancer. As a prominent research institution,...
This Project Grant award of $6,150,467, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a research project at Cedars-Sinai Medical Center to investigate the use of the drug simvastatin to improve patient-reported outcomes in individuals with chronic pancreatitis. The award has a period of performance from September 30, 2023 to September 29, 2027. As a leading academic medical center, Cedars-Sinai has an extensive track...
The federal Project Grant award, valued at $2,685,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research at Cedars-Sinai Medical Center in West Hollywood, CA aimed at "DEFINING HUMAN CORRELATES OF SUPER-EVASIVE DISSEMINATED TUMOR CELLS, THEIR PATHOLOGICAL RELEVANCE AND HOW TO ERADICATE THEM." The grant, which runs from July 1, 2025 to June 30, 2029, will fund advanced biomedical research...
The Department of Defense's Defense Health Agency awarded a $1,164,294 Project Grant to Cedars-Sinai Medical Center on September 15, 2024 under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a 4-year project to correlate prostate-specific membrane antigen (PSMA) expression with molecular profiles in prostate cancer. Cedars-Sinai, a non-profit hospital and academic medical center, will conduct this biomedical research to advance understanding of...
The Department of the Army Medical Command awarded Cedars-Sinai Medical Center a $601,684 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Novel DZ-Artemisinin for Treatment of Pancreatic Cancer. The three-year award beginning August 15, 2022 will fund the development of an innovative therapy using DZ-Artemisinin derivatives to treat pancreatic cancer at Cedars-Sinai's facilities located in West Hollywood, California. The Military...
This Project Grant award of $974,043.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research at Cedars-Sinai Medical Center in West Hollywood, California focused on "Early Cardiac Biomarkers of Inflammation and Remodeling in DMD" over the performance period from Sep 1, 2025 to Aug 31, 2029. Cedars-Sinai Medical Center is a prominent nonprofit academic medical...
Cedars-Sinai Medical Center was awarded a $1.9 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to support research on novel DZ-artemisinin for treatment of pancreatic cancer. The three-year award will fund preclinical research from August 2022 to August 2025 to investigate medical solutions for pancreatic cancer on the battlefield and for the American public through innovative biomedical research....
The Defense Health Agency awarded Cedars-Sinai Medical Center a $667,963 Project Grant to "INVESTIGATE EXTRACELLULAR MATRIX PROTEINS LOCAL AND SYSTEMIC ROLE IN PROMOTING SOFT TISSUE SARCOMA" over the period of 09/01/2023 to 08/30/2025. This award was made under the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. As a...
The Cedars-Sinai Medical Center was awarded a $414,537 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from August 1, 2022 to July 31, 2025 to develop artificial intelligence analysis of retinal images to stratify the risk of pancreatic ductal adenocarcinoma in individuals with new-onset diabetes. Through this funding, Cedars-Sinai Medical Center researchers...
This $4,089,970 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Cedars-Sinai Medical Center to investigate spatial reprogramming of tumor immune microenvironments through preoperative radiotherapy and immune checkpoint inhibition in HER2 negative breast cancer. The award will fund basic, translational, and clinical research over 4 years from September 2023 to August 2027 to develop new treatments,...